AMIGO2 and pancreatic adenocarcinoma: ONCOMINE analysis showed that AMIGO2 was abnormally expressed in most of the tissue samples, and it also showed the transcriptional levels of AMIGO2 were upregulated in PAAD patients (Figure 1A).